4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-17-000804
Director sold 3,150 shares at an average $18.52 ($58,345)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-08-18 | Sale : show line 1 in the form | −1,900 | $18.53 | $35,207 | 2,081,390 | I |
| 2017-08-21 | Sale : show line 2 in the form | −1,250 | $18.51 | $23,138 | 2,080,140 | I |
| Open-market sales · 3,150 sh · avg $18.52 · $58,345 | ||||||
Loading xslF345X03/vonemster_fm4aug182017.xml…